IGHE and allergic disease: The results of a study by Xie et al. reveal that the use of bone marrow-derived mast cell in mice with chronic asthma reduces respiratory tract inflammation and has a role in the remodelling and regeneration of lung tissue; accordingly, mast cell exosomes can be used as an anti-IgE agent in various allergic diseases [187, 188].